A HIPAA compliance assessment that becomes an operating program.
Valentra Labs assesses the HIPAA Security Rule safeguards — administrative, physical, and technical — and then operates them as live controls, so compliance is something you run, not a binder you assemble before an audit.
A point-in-time compliance assessment names the gaps and stops there. The administrative, physical, and technical safeguards drift from the policies that claim them, and the evidence is rebuilt by hand before every audit.
Valentra Labs grades each safeguard, then runs it as a control inside the Managed Security Program. Valentra Nexus carries every control's evidence and the work that keeps it current, and packages the result as a board-ready Decision Packet.
What you have
What a point-in-time compliance assessment leaves you with.
You have
A binder that named the gaps.
Safeguards graded administrative, physical, and technical.
But
The safeguards drift from the policies that claim them.
The evidence is rebuilt by hand before every audit.
A gap named is not a gap closed.
What it costs you
What that costs you.
01Audit prep that restarts from zero each cycle.
02Controls that pass on paper and fail in practice.
03No line from a safeguard to the work that maintains it.
The system
Each safeguard, run as a live control.
The assessment becomes an operating record — every safeguard graded, owned, and evidenced.
01AssetThe systems each HIPAA safeguard has to cover.
02RiskWhere a safeguard is weakest, ranked.
03ControlThe administrative, physical, and technical safeguards, run live.
04EvidenceProof each safeguard operates, tied to the control.
05WorkThe remediation that keeps a safeguard current.
06DecisionA board-ready Decision Packet on control health.
30-day impact
What changes in the first thirty days.
No ramp-up theater. The first month produces visible, measurable progress — by design.
Day 1–10Discover
Each HIPAA safeguard is mapped to the systems it governs and graded against current state.
Day 11–20Operate
Every safeguard becomes a live control with its evidence and the work that keeps it current.
Day 21–30Report
The first Decision Packet shows control health — what passes, what is in remediation, and why.
What you get
What you get.
01A graded safeguard baseline
Every administrative, physical, and technical safeguard scored against current state.
02Live controls, not a binder
Each safeguard runs as an operated control, not a line in a policy no one reads.
03Evidence tied to every control
The proof each safeguard operates, ready for an auditor on demand.
04A board-ready Decision Packet
Control health in one artifact leadership signs.
The artifact this produces
Every Valentra Labs program produces the same artifact: a board-ready Decision Packet
carrying the situation, options, recommendation, evidence, and approval chain —
generated by Valentra Nexus.
Decision Packet · v1.0
Q2 2026 — Crown-Jewel Risk Disposition
pkt_2026-04-17_a3f8e1·
Situation
Q2 program review covers the crown-jewel ePHI store and its supporting control envelope. 487 endpoints catalogued across three network segments; 12 unsanctioned SaaS surfaces detected by the shadow-IT scan. Continuous monitoring posture is operating; the residual question is risk acceptance for two compensating-control gaps surfaced this cycle.
Risk & Impact
14 critical findings scored against the revenue-at-risk model. Two compensating gaps (vendor-SOC-2 attestation lapse + patch-cycle #38 awaiting CAB sign-off) carry residual risk of $1.4M in unmitigated regulatory exposure if a HITRUST audit lands before remediation closes. Patient-data confidentiality remains the load-bearing impact dimension.
Options
Accept residual risk through Q3, with quarterly board re-review.
Accelerate remediation by re-prioritizing the patch cycle ahead of the planned Q3 platform migration (cost: 2 engineer-weeks).
Transfer risk via expanded cyber-insurance rider (cost: $48K/yr premium delta; coverage gap on ePHI exfiltration remains).
Recommendation
Pursue Option 2 — accelerate remediation. The 2 engineer-weeks of effort cost is recoverable in Q3; the residual exposure is asymmetric (regulatory floor of $1.4M vs. ~$120K labor delta). Document the patch-cycle re-prioritization as a logged decision with the program owner; close the SOC-2 attestation gap via vendor outreach in the same window. Insurance rider deferred to Q4 review.
Evidence
Twelve evidence artifacts back the recommendation — asset inventory, control mapping, vendor SOC-2 status, residual-risk model, patch-cycle telemetry, and the prior packet's audit trail. One control attestation is overridden with a documented compensating-control narrative; two vendor attestations are pending the Q2 refresh window.
Overridden per compensating-control narrative — see attached
Penetration test report — Q1 follow-up
#a5b6c7d8
stale
—
Prior packet audit trail — pkt_2026-01-09_b8c4e2
#b6c7d8e9
verified
—
Approval Chain
CIO and CISO have signed. The CCO signature is pending receipt of the vendor-SOC-2 refresh; the program owner has logged the override and the compensating-control narrative.
Chief Information OfficerM. AlvarezSigned 2026-04-17T14:08:11Z
Chief Information Security OfficerJ. ParkSigned 2026-04-17T14:18:42Z
The program maps each operating stage — asset, risk, control, evidence, work, decision —
to the frameworks healthcare cybersecurity teams report against. Valentra Nexus carries
the full framework-alignment grid; see how the stages line up on the platform page.
Valentra Labs turns a HIPAA Security Rule compliance assessment into an operating program: each administrative, physical, and technical safeguard runs as a live control on Valentra Nexus, with its evidence and upkeep packaged as a board-ready Decision Packet — not an audit-time binder.